Psychiatry research lacks an in-depth understanding of mood disorders phenotypes, leading to limited success of genetics studies of major depressive disorder (MDD). The dramatic …
There are marked sex differences in the prevalence, phenotypic presentation and treatment response for major depression. While genome-wide association studies (GWAS) adjust for …
The mechanisms of action of the rapid antidepressant effects of ketamine, an N-methyl-D- aspartate glutamate receptor antagonist, have not been fully elucidated. This study …
Background Depression affects women nearly twice as often as men, but the neurobiological underpinnings of this discrepancy are unclear. Preclinical studies in male …
A Palucha, A Pilc - Pharmacology & therapeutics, 2007 - Elsevier
Depression and anxiety represent a major problem. However, the current treatment of both groups of diseases is not satisfactory. As the glutamatergic system may play an important …
Medicinal therapies for mood disorders neither fully serve the efficacy needs of patients nor are they free of side-effect issues. Although monoamine-based therapies are the primary …
Drugs that act to reduce glutamatergic neurotransmission such as NMDA receptor antagonists exert antidepressant-like effects in a variety of experimental paradigms, but their …
A Alcaro, J Panksepp, J Witczak, DJ Hayes… - Neuroscience & …, 2010 - Elsevier
Major depressive disorder has recently been characterized by abnormal resting state hyperactivity in anterior midline regions. The neurochemical mechanisms underlying resting …
S Miyata, M Taniguchi, Y Koyama, S Shimizu… - Scientific reports, 2016 - nature.com
Repeated stressful events are associated with the onset of major depressive disorder (MDD). We previously showed oligodendrocyte (OL)-specific activation of the …